Home » Basilea to Continue Late-Stage Antifungal Study
Basilea to Continue Late-Stage Antifungal Study
Swiss biotechnology group Basilea said it would resume recruitment of patients into a
late-stage trial of an antifungal treatment in the first half of 2010 after a U.S. safety panel recommended the study’s continuation.
The Post Chronicle
The Post Chronicle
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May